Please login to the form below

Not currently logged in

CROS NT acquires biometrics firm Stat-Tech

Deal sees Italian contract research organisation gain US base

CROS NT has snapped up US-based clinical research organisation (CRO) Stat-Tech Services in a move that boosts its biometrics offering and gives it a foothold in the US.

The Italian-headquartered CRO said it was attracted by Stat-Tech's “excellent reputation for quality and service” and medical devices experience.

CROS NT CEO and president Paolo Morelli said: "The experience and quality of the Stat-Tech team will add strong value to CROS NT, adding the important area of medical devices to our portfolio and allowing us to improve our services to our existing US customers by being closer to them. 

“I was impressed with the reputation of their management and their strong leadership, which we can combine with the existing groups in Europe to field a great team globally."

CROS NT's expansion plans, which saw it open its first UK office last year, will add its new US location to existing bases in Verona, Italy and Augsberg, Germany.

The financial details of the transaction, which is expected to be completed later this month, remain confidential. Once finalised the deal will trade as “Stat-Tech Services, part of CROS NT Group”.

George DeMuth, one of Stat-Tech's founders and incoming chief operating officer of CROS NT's US Operations, said: "We are very excited about joining CROS NT. This move allows us to provide a broader range of services and additional resources to our existing clients; and provides additional opportunities for growth.”

Based in Chapel Hill, North Carolina, Stat-Tech was found in 1996 and provides biometrics services for medical devices, biologics, and small molecule drugs.

11th September 2013

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...